Search

GlaxoSmithKline PLC

Cerrado

SectorSanidad

1,400.5 -1.41

Resumen

Variación precio

24h

Actual

Mínimo

1395

Máximo

1401

Métricas clave

By Trading Economics

Ingresos

1.3B

1.8B

Ventas

-601M

7.5B

P/B

Media del Sector

18.395

40.048

BPA

44.9

Rentabilidad por dividendo

4.45

Margen de beneficios

23.576

Empleados

68,629

EBITDA

2B

3.1B

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+13.44% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

4.45%

2.45%

Próximas Ganancias

29 oct 2025

Fecha Próximo Dividendo

9 oct 2025

Próxima Fecha de Ex Dividendo

14 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

848K

57B

Apertura anterior

1401.91

Cierre anterior

1400.5

Noticias sobre sentimiento de mercado

By Acuity

31%

69%

76 / 375 Clasificación en Healthcare

GlaxoSmithKline PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

30 jul 2025, 06:50 UTC

Ganancias

GSK Upbeat on Guidance After Specialty Medicines Boost Sales

18 jul 2025, 09:39 UTC

Principales Movimientos del Mercado

GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt

2 jun 2025, 10:49 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Theravance Shares Rise Premarket on Sale of Trelegy Royalties

14 may 2025, 11:01 UTC

Adquisiciones, fusiones, absorciones

GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion - Update

14 may 2025, 06:39 UTC

Adquisiciones, fusiones, absorciones

GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion

12 may 2025, 09:36 UTC

Principales Movimientos del Mercado

Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices

30 jul 2025, 09:08 UTC

Charlas de Mercado
Ganancias

GSK Results Look Solid, But Benefit From Temporary Effects -- Market Talk

30 jul 2025, 06:06 UTC

Ganancias

Correct: GSK PLC 2Q EPS 35.5p

30 jul 2025, 06:00 UTC

Ganancias

GSK PLC 2Q EPS 35.5p

30 jul 2025, 06:00 UTC

Ganancias

GSK PLC 2Q Pretax Pft GBP1.89B

30 jul 2025, 06:00 UTC

Ganancias

GSK PLC 2Q Net Pft GBP1.44B

30 jul 2025, 06:00 UTC

Ganancias

GSK PLC 2Q Adj EPS 46.5p

30 jul 2025, 06:00 UTC

Ganancias

GSK PLC 2Q Turnover GBP7.99B

30 jul 2025, 06:00 UTC

Ganancias

GSK PLC 2Q Pre-items, Pretax Pft GBP2.5B

30 jul 2025, 06:00 UTC

Ganancias

GSK PLC 2Q Oper Pft GBP2.02B

28 jul 2025, 10:51 UTC

Charlas de Mercado

U.S.-EU Tariff Deal, Earnings Could Keep Pharma Rally Going -- Market Talk

18 jul 2025, 09:05 UTC

Acciones populares

Stocks to Watch Friday: Netflix, Norfolk Southern, Amex -- WSJ

7 jul 2025, 15:00 UTC

Adquisiciones, fusiones, absorciones

GSK Completes Acquisition of Efimosfermin

2 jun 2025, 10:00 UTC

Adquisiciones, fusiones, absorciones

Theravance Biopharma Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225M

15 may 2025, 15:20 UTC

Principales Noticias

New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel -- WSJ

14 may 2025, 06:08 UTC

Adquisiciones, fusiones, absorciones

GSK PLC to Buy Efimosfermin from Boston Pharmaceuticals

14 may 2025, 06:03 UTC

Adquisiciones, fusiones, absorciones

GSK PLC: Deal Includes Potential Success-Based Milestone Payments of $800M

14 may 2025, 06:03 UTC

Adquisiciones, fusiones, absorciones

GSK PLC to Pay $1.2B Upfront

14 may 2025, 06:03 UTC

Adquisiciones, fusiones, absorciones

GSK to Buy Efimosfermin for up to $2B

14 may 2025, 06:00 UTC

Adquisiciones, fusiones, absorciones

GSK to Buy Efimosfermin

12 may 2025, 12:07 UTC

Charlas de Mercado

Trump's Drug Price Cap Plan Is 'Alarming' for Pharma Sector -- Market Talk

12 may 2025, 07:20 UTC

Charlas de Mercado

Pharma Shares Face Risks From Trump's Pricing Plans -- Market Talk

30 abr 2025, 08:54 UTC

Charlas de Mercado
Ganancias

GSK Investors Turn to U.S. Policy Outlook After Solid Results -- Market Talk

30 abr 2025, 07:49 UTC

Charlas de Mercado
Ganancias

GSK's Specialty Meds Sustain Growth, Blenrep Comeback Remains Key -- Market Talk

30 abr 2025, 07:06 UTC

Charlas de Mercado
Ganancias

GSK Outperforms Expectations Despite RSV Vaccine Setback -- Market Talk

GlaxoSmithKline PLC previsión

Precio Objetivo

By TipRanks

13.44% repunte

Estimación a 12 Meses

Media 1,584.25 GBX  13.44%

Máximo 2,290 GBX

Mínimo 1,290 GBX

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para GlaxoSmithKline PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

13 ratings

2

Comprar

8

Mantener

3

Vender

Sentimiento

By Acuity

76 / 375 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.